ERBB2 and triple-negative breast carcinoma: Beginning with the HR-negative and ERBB2-negative subtype, commonly referred to as triple-negative breast cancer, our results indicate that rates have held essentially constant across all racial and ethnic groups among women younger than 50 years, but marked differences were observed among women 65 years or older.